Akari Therapeutics 뉴스 - AKTX

기업명	주식 심볼	시장	주식 타입
Akari Therapeutics PLC	AKTX	나스닥	주식예탁증서 (DR)

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	-0.005	-0.42%	1.185	06:16:11

개장가	저가	고가	종가	전일 종가
1.19	1.17	1.20	1.185	1.19

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
16/03/2024	01:53	PRNUS	Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
12/03/2024	06:25	EDGAR2	Form 425 - Prospectuses and communications, business..
12/03/2024	06:24	EDGAR2	Form 8-K - Current report
06/03/2024	06:57	EDGAR2	Form 425 - Prospectuses and communications, business..
05/03/2024	22:34	EDGAR2	Form 425 - Prospectuses and communications, business..
05/03/2024	22:28	EDGAR2	Form 8-K - Current report
10/01/2024	07:25	EDGAR2	Form D - Notice of Exempt Offering of Securities
05/01/2024	02:34	EDGAR2	Form SC 13D/A - General statement of acquisition of..
03/01/2024	09:56	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
03/01/2024	09:49	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
03/01/2024	08:58	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
03/01/2024	08:41	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
03/01/2024	06:30	EDGAR2	Form 8-K - Current report
01/12/2023	22:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/2023	22:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/10/2023	05:15	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
21/10/2023	06:00	EDGAR2	Form SC 13D/A - General statement of acquisition of..
21/10/2023	05:29	EDGAR2	Form POS AM - Post-Effective amendments for registration..
21/10/2023	05:28	EDGAR2	Form POS AM - Post-Effective amendments for registration..
21/10/2023	05:23	EDGAR2	Form F-3 - Registration statement by foreign private issuers
13/10/2023	05:43	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
29/09/2023	21:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/09/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/2023	22:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/08/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/08/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/08/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/07/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/07/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/07/2023	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/07/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/07/2023	05:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/07/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/07/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/07/2023	05:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/05/2023	05:05	GLOBE	Aspira Women’s Health Names Torsten Hombeck as Chief..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

AKTX Akari Therapeutics PLC

최근 뉴스

AKTX 과거 데이터 - 1일

AKTX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Akari Therapeutics PLC (AKTX) 뉴스

AKTX Akari Therapeutics PLC

최근 뉴스

AKTX 과거 데이터 - 1일

AKTX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기